These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1208 related articles for article (PubMed ID: 33004546)
21. Effect of Guo Y; Zhang Y; Gerhard M; Gao JJ; Mejias-Luque R; Zhang L; Vieth M; Ma JL; Bajbouj M; Suchanek S; Liu WD; Ulm K; Quante M; Li ZX; Zhou T; Schmid R; Classen M; Li WQ; You WC; Pan KF Gut; 2020 Sep; 69(9):1598-1607. PubMed ID: 31857433 [TBL] [Abstract][Full Text] [Related]
22. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection. Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009 [TBL] [Abstract][Full Text] [Related]
23. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G; Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399 [TBL] [Abstract][Full Text] [Related]
24. Population based Helicobacter pylori screening and eradication: advances versus side effects. Tepes B Curr Pharm Des; 2014; 20(28):4501-9. PubMed ID: 24180403 [TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. Liu KS; Wong IO; Leung WK World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668 [TBL] [Abstract][Full Text] [Related]
26. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients. Massarrat S; Haj-Sheykholeslami A; Mohamadkhani A; Zendehdel N; Rakhshani N; Stolte M; Mirzaei M; Saliminejhad M; Saeidi S; Shahidi M Arch Iran Med; 2012 Nov; 15(11):664-9. PubMed ID: 23102241 [TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Chen HN; Wang Z; Li X; Zhou ZG Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452 [TBL] [Abstract][Full Text] [Related]
29. Prevention of Gastric Cancer: Eradication of Helicobacter Pylori and Beyond. Tsukamoto T; Nakagawa M; Kiriyama Y; Toyoda T; Cao X Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28771198 [TBL] [Abstract][Full Text] [Related]
30. Rationale for a Helicobacter pylori Test and Treatment Strategy in Gastroesophageal Reflux Disease. Vakil N Gastroenterol Clin North Am; 2015 Sep; 44(3):661-6. PubMed ID: 26314675 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing. Park CH; Lee AR; Lee YR; Eun CS; Lee SK; Han DS Helicobacter; 2019 Feb; 24(1):e12547. PubMed ID: 30440093 [TBL] [Abstract][Full Text] [Related]
32. Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer. Choi IJ; Kook MC; Kim YI; Cho SJ; Lee JY; Kim CG; Park B; Nam BH N Engl J Med; 2018 Mar; 378(12):1085-1095. PubMed ID: 29562147 [TBL] [Abstract][Full Text] [Related]
33. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. Suzuki H; Mori H J Gastroenterol; 2018 Mar; 53(3):354-361. PubMed ID: 29138921 [TBL] [Abstract][Full Text] [Related]
34. Mass eradication of Chiang TH; Chang WJ; Chen SL; Yen AM; Fann JC; Chiu SY; Chen YR; Chuang SL; Shieh CF; Liu CY; Chiu HM; Chiang H; Shun CT; Lin MW; Wu MS; Lin JT; Chan CC; Graham DY; Chen HH; Lee YC Gut; 2021 Feb; 70(2):243-250. PubMed ID: 32792335 [TBL] [Abstract][Full Text] [Related]
35. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer. Cho SJ; Choi IJ; Kook MC; Yoon H; Park S; Kim CG; Lee JY; Lee JH; Ryu KW; Kim YW Aliment Pharmacol Ther; 2013 Sep; 38(5):477-89. PubMed ID: 23822578 [TBL] [Abstract][Full Text] [Related]
36. Consensus on eradication of Helicobacter pylori and prevention and control of gastric cancer in China (2019, Shanghai). Du Y; Zhu H; Liu J; Li J; Chang X; Zhou L; Chen M; Lu N; Li Z J Gastroenterol Hepatol; 2020 Apr; 35(4):624-629. PubMed ID: 31788864 [TBL] [Abstract][Full Text] [Related]
37. Characteristics and predictors of gastric cancer after Shichijo S; Hirata Y World J Gastroenterol; 2018 May; 24(20):2163-2172. PubMed ID: 29853734 [No Abstract] [Full Text] [Related]
38. Risk of gastric cancer in children with Helicobacter pylori infection. Cam S Asian Pac J Cancer Prev; 2014; 15(22):9905-8. PubMed ID: 25520126 [TBL] [Abstract][Full Text] [Related]
39. Chilean consensus by expert panel using the Delphi technique for primary and secondary prevention of gastric cancer. Corsi Sotelo Ó; Pizarro Rojas M; Rollán Rodríguez A; Silva Figueroa V; Araya Jofré R; Bufadel Godoy ME; Cortés González P; González Donoso R; Fuentes López E; Latorre Selvat G; Medel-Jara P; Reyes Placencia D; Pizarro Véliz M; Garchitorena Marqués MJ; Zegers Vial MT; Crispi Galleguillos F; Espinoza MA; Riquelme Pérez A Gastroenterol Hepatol; 2024 Oct; 47(8):845-857. PubMed ID: 38311004 [TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori-related precancerous lesions in Turkey: a retrospective endoscopic surveillance study. Bas B; Dinc B Croat Med J; 2020 Aug; 61(4):319-325. PubMed ID: 32881429 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]